Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine gel for postherpetic neuralgia
CTR20182203Phase 3Completed
- Sponsor
- Hainan Huiyuantang Pharmaceutical
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in postherpetic neuralgia (PHN), sponsored by Hainan Huiyuantang Pharmaceutical. Started Nov 2018; status: completed.
02
Drugs
lidocaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on CTR20182203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182203.